Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2–3 diffuse large B-cell lymphoma

A. Plonquet; C. Haioun; J.-P. Jais; A.-L. Debard; G. Salles; M.-C. Bene; P. Feugier; C. Rabian; O. Casasnovas; M. Labalette; E. Kuhlein; J.-P. Farcet; J.-F. Emile; C. Gisselbrecht; M.-H. Delfau-Larue

doi:10.1093/annonc/mdm110

Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2–3 diffuse large B-cell lymphoma

Annals of Oncology ◽

10.1093/annonc/mdm110 ◽

2007 ◽

Vol 18 (7) ◽

pp. 1209-1215 ◽

Cited By ~ 52

Author(s):

A. Plonquet ◽

C. Haioun ◽

J.-P. Jais ◽

A.-L. Debard ◽

G. Salles ◽

...

Keyword(s):

Natural Killer Cell ◽

Clinical Outcome ◽

B Cell ◽

Cell Count ◽

Peripheral Blood ◽

Cell Lymphoma ◽

Killer Cell ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Modulation the expression of natural killer cell activating receptor (NKp44) in the peripheral blood of diffuse large B-cell lymphoma patients and the correlation with clinic pathological features

Clinical Immunology ◽

10.1016/j.clim.2017.12.003 ◽

2018 ◽

Vol 188 ◽

pp. 38-44 ◽

Cited By ~ 1

Author(s):

Enas Said Essa ◽

Gehan Abd-Elfatah Tawfeek ◽

Suzan Ahmed El Hassanin ◽

Khloud Gamal Mohammed Emara

Keyword(s):

Natural Killer Cell ◽

B Cell ◽

Peripheral Blood ◽

Cell Lymphoma ◽

Killer Cell ◽

B Cell Lymphoma ◽

Pathological Features ◽

Large B Cell Lymphoma ◽

Activating Receptor ◽

Large B Cell

Download Full-text

Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-3270 ◽

2019 ◽

Vol 25 (15) ◽

pp. 4634-4643 ◽

Cited By ~ 12

Author(s):

Magdalena Klanova ◽

Mikkel Z. Oestergaard ◽

Marek Trněný ◽

Wolfgang Hiddemann ◽

Robert Marcus ◽

...

Keyword(s):

Natural Killer Cell ◽

Follicular Lymphoma ◽

B Cell ◽

Cell Count ◽

Cell Lymphoma ◽

Killer Cell ◽

B Cell Lymphoma ◽

Prognostic Impact ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Diffuse large B cell lymphoma expressing the natural killer cell marker CD56

Pathology International ◽

10.1046/j.1440-1827.1999.00929.x ◽

1999 ◽

Vol 49 (8) ◽

pp. 752-758 ◽

Cited By ~ 13

Author(s):

Toru Sekita ◽

Jun-ichi Tamaru ◽

Kouichi Isobe ◽

Kenichi Harigaya ◽

Syu-ichi Masuoka ◽

...

Keyword(s):

Natural Killer Cell ◽

B Cell ◽

Natural Killer ◽

Cell Lymphoma ◽

Killer Cell ◽

B Cell Lymphoma ◽

Cell Marker ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Review for "Improving the IPI score using peripheral blood counts: results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma"

10.1002/hon.2757/v1/review2 ◽

2020 ◽

Keyword(s):

B Cell ◽

Multicenter Study ◽

Peripheral Blood ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Large Multicenter Study ◽

Large B Cell

Download Full-text

Review for "Improving the IPI score using peripheral blood counts: results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma"

10.1002/hon.2757/v1/review1 ◽

2020 ◽

Keyword(s):

B Cell ◽

Multicenter Study ◽

Peripheral Blood ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Large Multicenter Study ◽

Large B Cell

Download Full-text

LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy

Clinical and Experimental Medicine ◽

10.1007/s10238-015-0396-8 ◽

2015 ◽

Vol 17 (1) ◽

pp. 1-8 ◽

Cited By ~ 23

Author(s):

Wei Peng ◽

Jianzhong Wu ◽

Jifeng Feng

Keyword(s):

Clinical Outcome ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Chop Chemotherapy ◽

Large B Cell Lymphoma ◽

Favorable Clinical Outcome ◽

Large B Cell

Download Full-text

Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.08.096 ◽

2017 ◽

Vol 17 (12) ◽

pp. e91-e97 ◽

Cited By ~ 2

Author(s):

Daisuke Katoh ◽

Yotaro Ochi ◽

Tomohiro Yabushita ◽

Yuichiro Ono ◽

Nobuhiro Hiramoto ◽

...

Keyword(s):

B Cell ◽

Peripheral Blood Lymphocyte ◽

Peripheral Blood ◽

Blood Lymphocyte ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Lymphocyte To Monocyte Ratio ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP

Annals of Hematology ◽

10.1007/s00277-010-0926-0 ◽

2010 ◽

Vol 89 (8) ◽

pp. 783-787 ◽

Cited By ~ 15

Author(s):

Panagiotis Samaras ◽

Helen Heider ◽

Sarah R. Haile ◽

Ulf Petrausch ◽

Niklaus G. Schaefer ◽

...

Keyword(s):

Clinical Outcome ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Large B Cell ◽

Statin Use

Download Full-text

B-Cell Lymphoma Unclassifiable with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt’s Lymphoma: Comparison Study of Clinical Outcome and Treatment Response

10.17303/jcap.2015.2.101 ◽

2019 ◽

pp. 1-5

Keyword(s):

Clinical Outcome ◽

B Cell ◽

Treatment Response ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Burkitt’S Lymphoma ◽

Burkitt's Lymphoma ◽

Comparison Study ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-009-0586-4 ◽

2009 ◽

Vol 135 (10) ◽

pp. 1421-1428 ◽

Cited By ~ 11

Author(s):

Takeshi Hara ◽

Hisashi Tsurumi ◽

Naoe Goto ◽

Nobuhiro Kanemura ◽

Takeshi Yoshikawa ◽

...

Keyword(s):

Clinical Outcome ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Soluble Fas ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text